Clinical Trial Update: Rezdiffra Pregnancy and Lactation Registry

View source ↗

Summary

This clinical trial update notes that Madrigal Pharmaceuticals' Rezdiffra (resmetirom) pregnancy and lactation registry (NCT07541469) is currently recruiting to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• REZDIFFRA (RESMETIROM)

Snippet

Sponsor: Madrigal Pharmaceuticals, Inc. | Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis | Status: RECRUITING